Polar Capital Holdings »

Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Polar Capital Holdings

Quarter-by-quarter ownership of Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Polar Capital Holdings from 13F filings

Historical chart of Polar Capital Holdings investment in Alnylam Pharmaceuticals Inc Note 1.000 9/1

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals Inc Note 1.000 9/1 held by Polar Capital Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals Inc Note 1.000 9/1 by Polar Capital Holdings

Quarter filed Position value Share count Share price at filing
2023-09-30 $3.7M 4.0M 0.93

More positions owned by Polar Capital Holdings

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl C (GOOG)
Advanced Micro Devices (AMD)
Alphabet Cap Stk Cl A (GOOGL)
Arch Cap Group Ord (ACGL)
Amazon (AMZN)
Renaissance Re Holdings Ltd Cmn (RNR)
Chubb (CB)
Servicenow (NOW)
Marsh & McLennan Companies (MMC)
Crowdstrike Hldgs Cl A (CRWD)
Hubspot (HUBS)

View all positions for Polar Capital Holdings

Top funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1

Ubs Global Asset Management Americas
Readystate Asset Management
Calamos Advisors
Steelhead Partners
Aequim Alternative Investments
Davidson Kempner Capital Management
Wolverine Asset Management
Lazard Asset Management
Zazove Associates
Shenkman Capital Management
CNH Partners
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Capstone Investment Advisors
Citadel Advisors
MacKay Shields

View all funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1